Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hidemasa, Tamai"'
Autor:
Tomoya, Hatakeyama, Kazuki, Sakai, Sosuke, Komiyama, Hidemasa, Tamai, Shiro, Ogino, Toshikazu, Akami, Yuji, Ueda, Takeshi, Mazaki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(13)
An 80-year-old women admitted to our hospital with jaundice. Abdominal contrast-enhanced CT scan revealed an enhanced tumor, measuring 10 mm, at the duodenal ampulla. Upper endoscopy showed a submucosal tumor-like lesion at the duodenal ampulla. Immu
Autor:
Tomoya, Hatakeyama, Kazuki, Sakai, Sosuke, Komiyama, Hidemasa, Tamai, Shiro, Ogino, Toshikazu, Akami, Yuji, Ueda, Takeshi, Mazaki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(13)
An intra-abdominaldesmoid tumor, especially omentaldesmoid tumor, is rare. Here, we report a case of omentaldesmoid tumor after a smallbowelresection for gastrointestinalstromaltumor (GIST). A 73-year-old man underwent a partial resection of smallbow
Autor:
Suyu Shu, Katsuya Deguchi, Hidemasa Tamai, Li-Xin Wang, Rongxiu Zheng, Peter A. Cohen, Satoshi Watanabe
Publikováno v:
The Journal of Immunology. 181:3291-3300
Suppression of tumor-specific T cell sensitization is a predominant mechanism of tumor escape. To identify tumor-induced suppressor cells, we transferred spleen cells from mice bearing progressive MCA205 sarcoma into sublethally irradiated mice. Thes
Autor:
Gary K. Koski, Peter A. Cohen, Hidemasa Tamai, Katsuya Deguchi, Suyu Shu, Rongxiu Zheng, Satoshi Watanabe
Publikováno v:
Clinical Immunology. 127:66-77
Curative immunotherapy against spontaneous metastases of poorly immunogenic tumors has been difficult to demonstrate, but it is highly relevant to clinical disease conditions. The 4T1 mammary carcinoma shares many characteristics of human mammary can
Autor:
Rongxiu Zheng, Hidemasa Tamai, Hong-Ming Hu, Satoshi Watanabe, H Kuriyama, Peter A. Cohen, Gregory E. Plautz, Jorgen Kjaergaard, Suyu Shu, Andrew D. Weinberg
Publikováno v:
Cellular Immunology. 243:30-40
Dendritic-tumor heterokaryons generated by electrofusion are highly immunogenic. In animal studies, a single vaccination was therapeutic for tumors established in the lung, skin, and brain. However, effective therapy required a third signal which cou
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 64:449-452
膵頭十二指腸切除術後の膵空腸吻合縫合不全,膵液瘻は今日においても治療に難渋する合併症である.今回,われわれは膵頭十二指腸切除術後の難治性膵液瘻に対して非観血的に内瘻化し,良
Autor:
Hidemasa Tamai, Junya Kuroda, Yutaka Kobayashi, Toshikazu Yoshikawa, Hisakazu Yamagishi, Atsushi Omoto, Kaori Okugawa, Hiroshi Fujiki
Publikováno v:
Acta Haematologica. 105:237-240
The liver is an uncommon primary site for malignant lymphoma, and primary hepatic lymphoma has been found to make up 0.4% of all extranodal lymphomas. We report a rare case of a 75-year-old Japanese male with primary hepatic Burkitt’s lymphoma, acc
Autor:
Daisuke, Ichikawa, Shuhei, Komatsu, Takeshi, Kubota, Kazuma, Okamoto, Katsuya, Deguchi, Hidemasa, Tamai, Takayoshi, Obayashi, Kazutomo, Kitagawa, Koji, Soga, Koji, Inoue, Nobuki, Yamaoka, Tsutomu, Imanishi, Akeo, Hagiwara, Eigo, Otsuji
Publikováno v:
Anticancer research. 33(11)
This study aimed to examine the effect of hospital volume on long-term outcomes of patients who underwent laparoscopic gastrectomy for clinical stage I gastric cancer.A total of 420 patients with clinical stage I gastric cancer who underwent laparosc
Autor:
Yuji Ueda, Yoshiki Yamamoto, Tsuyoshi Itoh, Hidemasa Tamai, Takeshi Shimizu, Hisakazu Yamagishi, Keiji Shimizu, Kei Naito, Atsushi Shiozaki, Nobuaki Fuji, Iwamoto A
Publikováno v:
Japanese journal of clinical oncology. 37(2)
Primary malignant melanoma of the esophagus (PMME) is a very rare disease with an extremely poor prognosis. Surgery is currently considered its best treatment, while any other measures are ineffective. We studied the effect of active specific immunot
Autor:
Yuko Matsuura, Tsuyoshi Itoh, Hidemasa Tamai, Kenichiro Imura, Hisakazu Yamagishi, Kazuki Nakane, Junji Kohara, Yutaro Yano, Keiichi Kawai, Takahisa Takeda, Takashi Hayashi, Yuji Ueda, Keiji Shimizu, Kei Naito, Atsuko Takeda
Publikováno v:
International journal of oncology. 29(3)
Recently, dendritic cells (DCs) and DC-tumor cell hybrids (DC-tumor hybrids) have been used for cancer vaccine therapy in a clinical trial. DC-tumor hybrids combine the potent antigen-presenting capacity of DCs with the ability to present all tumor a